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a b s t r a c t
Bulk crystallisation of protein therapeutic molecules towards their controlled drug delivery is of inter-
est to the biopharmaceutical industry. The complexity of biotherapeutic molecules is likely to lead to
complex material properties of crystals in the solid state and to complex transitions. This complexity
is explored using batch crystallised lysozyme as a model. The effects of drying and milling on the solid-
state transformations of lysozyme crystalsweremonitored using differential scanning calorimetry (DSC),
X-ray powder diffraction (XRPD), FT-Raman, and enzymatic assay. XRPD was used to characterise crys-
tallinity and thesedata supported thoseof crystalline lysozymewhichgaveadistinctiveDSC thermogram.
The apparent denaturation temperature (Tm) of the amorphous lysozyme was ∼201 ◦C, while the Tm of
the crystalline form was ∼187 ◦C. Raman spectra supported a more -helix rich structure of crystalline
lysozyme. This structure is consistent with reduced cooperative unit sizes compared to the amorphous
lysozyme and is consistent with a reduction in the Tm of the crystalline form. Evidence was obtained that
milling also induced denaturation in the solid-state, with the denatured lysozyme showing no thermal
transition. The denaturation of the crystalline lysozyme occurred mainly through its amorphous form.
Interestingly, themechanical denaturation of lysozymedid not affect its biological activity on dissolution.
Lysozyme crystals on drying did not become amorphous, while milling-time played a crucial role in the
crystalline-amorphous-denatured transformations of lysozyme crystals. DSC is shown to be a key tool to
monitor quantitatively these transformations.
© 2015 Elsevier B.V. All rights reserved.
1. Introduction
Lysozymes are a group of enzymes deﬁned as 1,4--N-
acetylmuramidases cleaving the glycosidic bond in the bacterial
peptidoglycan. Hen egg white lysozyme (HEWL) is a single chain
polypeptide of 129 amino acids cross-linked with four disulﬁde
bridges resulting in a molecular weight of 14307Da [1]. HEWL has
the ability to lyse bacteria, and therefore it has particular interest
for application in food and pharmaceutical products [2]. Previous
researchers assured its potent antimicrobial efﬁciency [3] and its
safety [4]. Also, other research has resulted in improved intranasal
absorption and delivery [5] and lung delivery [6].
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Zhou et al. [7] made lysozyme containing mats and they veri-
ﬁed its excellent antibacterial activity against Escherichia coli and
Staphylococcus aureus, and therefore, these mats have promis-
ing uses in antimicrobial packing, tissue engineering, and wound
dressing. Sax and Winter [8] prepared sustained release lysozyme
containing implants using hot melt extrusion. Schlocker et al. [9]
used milling to prepare protein-loaded microparticles in industrial
quantities. Milling has also been used to prepare protein parti-
cles suitable for pulmonary delivery [10]. However, milling and
other pharmaceutical processes (e.g., drying, mixing) may produce
uncontrollable variation of protein solid states (i.e., crystal struc-
tureandcrystal habit) andalso lossofproteinactivity [11].Different
lyophilized solid forms of proteins have been shown to produce
different dissolution rates for reconstitution [12]. The stability of
crystalline lysozyme has been shown to be greater than that of
the amorphous form [13,14]. Therefore, it is essential to monitor
the solid state transformations of lysozyme during pharmaceutical
processes.
Differential scanning calorimetry (DSC) is a well-established
and widely used technique to monitor solid state transformations.
http://dx.doi.org/10.1016/j.jpba.2015.05.011
0731-7085/© 2015 Elsevier B.V. All rights reserved.
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However, the thermal transitions of lysozyme, in common with
other proteins, are usually characterized in the solution state,
and often using a high-sensitivity differential scanning calorime-
ter (HSDSC), which is capable of detecting the small changes in
enthalpy that arise when proteins unfold within their solutions
[15]. Modulated temperature differential scanning calorimetry
[16] and thermally stimulated depolarized current [17] have been
tested as alternatives. However, the thermal transitions in the
solution state cannot differentiate the different solid forms. There-
fore, researchers have studied the thermal transitions of lysozyme
in solid state using conventional solid-state DSC. However, their
results did not recognize the discrepancy between the thermal
behaviours of the amorphous and crystalline lysozyme powders
[13,14,18,19].
There is a renewed interest in lysozyme, and its solid state form
can have a signiﬁcant effect on dissolution and stability.Wewished
toexplorehowpre-treatmentof lysozymecrystals affected thermal
behaviour, in an attempt to use thermal proﬁles as a ﬁngerprinting
indicator of prior treatment. In this study, we prepare lysozyme
crystals to be dried and/or milled, and appropriate mixtures of
the treated forms were prepared. Our aim is to use DSC to mon-
itor the potential solid state transformations of lysozyme during
the treatment processes. We use Powder X-ray diffraction (PXRD),
FT-Raman, and enzymatic assay for reference. To our knowledge
this is the ﬁrst application of DSC for the quantitative detection of
crystalline, amorphous and denatured lysozyme forms.
2. Materials and methods
2.1. Materials
Hen egg-white lysozyme (HEWL) (purity; 95%) (Biozyme Lab-
oratories, UK), Micrococcus lysodeikticus (Sigma-Aldrich), sodium
chloride (NaCl) (99.5%) (Sigma-Aldrich) and sodium acetate anhy-
drous (purity; 98%) (BDHChemicals Ltd., Poole,UK)werepurchased
as indicated. The purchased lysozyme sample was considered to be
unprocessed lysozyme. Water was deionised and double distilled.
2.2. Sample preparation
2.2.1. Preparation lysozyme crystals using batch crystallization
method
One litre of a solution of lysozyme 4% w/v in sodium acetate
buffer (pH 4.6; 0.1M) and one litre of a solution of sodium chloride
10% w/v in the same buffer were separately passed through a 0.2
micron ﬁlter and then mixed in a glass container. The produced
solution contained 2% w/v lysozyme and 5% w/v NaCl. This solution
was then sealed andkept for tendays at 20 ◦C. Crystals formedwere
collected by ﬁltration. Adsorbed water was removed by air drying
(5h). These procedures were used to prepare lysozyme crystals by
a batch crystallisation method [13].
2.2.2. Preparation of dried lysozyme crystals
A glass column of dimensions 2m (three loops)×6mm (outer
diameter)×4mm (inner diameter), was packed with lysozyme
crystals. Anhydrous nitrogen gas was passed through the packed
columnat a ﬂow rate of 10ml/min, 30 ◦C and zero relative humidity
for 10 days.
2.2.3. Preparation of milled dried lysozyme powders
Milling was achieved by rotating a marble pestle over the pow-
derwithin amarblemortar at ∼45 cycles perminute (cpm).Milling
times of 3, 10, 20, 30, 45, and 60minwere used to produce different
samplesofmilleddried crystals, named3M,10M,20M,30M,45M,
and 60M, respectively. Another two batches of 3M, 10M, 20M and
60M were also prepared for reference.
2.2.4. Preparation of amorphous lysozyme powders with different
salt content
Precipitated samples were also prepared to explain the effect of
NaCl on thermal behaviour of lysozymeparticles. These amorphous
samples were prepared using the same principle of batch crystal-
lization method. Hence solutions containing 2% w/v lysozyme plus
different amount of NaCl (0, 0.096, 0.16, and 0.8% w/v) in deionised
water were dried under vacuum at a temperature 30 ◦C for two
days to produce lysozyme powders theoretically containing 0, 24,
40 and 200 NaCl molecules for each lysozyme molecule, respec-
tively. These four lysozyme samples were named P0, P24, P40, and
P200, respectively, and their amorphous nature was conﬁrmed by
XRPD.
2.2.5. Preparation of lysozyme mixtures from two different
samples
Unprocessed lysozyme and the 3M sample were mixed at dif-
ferent ratios (w/w) of 3:7, 5:5, and 7:3 in 100mg samples. The
mixtures were lightly mixed in a mortar with a spatula for 10min
and then in a small plastic bag for 10min to ensure their homo-
geneity.
2.3. Microscopy
A Zeiss Axioplan2 polarizing microscope (Carl Zeiss Vision
GmbH; Hallbergmoos, Germany) was used to visualize the sam-
ples. The accompanying software (Axio Vision 4.2) was then used
to determine the projected area diameters of the powders.
2.4. Thermogravimetric analysis (TGA)
The water content of each sample was estimated using Thermo
Gravimetric Analysis (TGA 7 Perkin Elmer Ltd., Beaconsﬁeld, UK).
Samples of 3–10mg were heated from 30 ◦C to 210 ◦C at a scan rate
of 10 ◦C/min in aluminium pan under nitrogen ﬂow at 20ml/min.
Each sample was analysed in triplicate. The decrease in the weight
before decomposition was calculated and was considered as water
content. TGA results were validated by re-analyzing the water
content of some samples using Karl Fischer Titration (KFT) (701
KF Titrino with 703 Ti stand, Metrohm, Switzerland). Using TGA
instead of KFT is that only a few mg is enough for TGA.
2.5. Powder X-ray diffraction (PXRD)
X-raypowder diffractionpatterns of the powderswere obtained
using a Siemens D5000 diffractometer (Siemens, Karlsruhe,
Germany), using CuK radiation (=1.5418 A˚). The generator was
set to 40kV and 30mA. Samples were placed into plastic sample
holder with zero background and levelled using a glass cover slide.
Samples were scanned over an angular range of 2–10◦ (2), with
a step size of 0.001◦ and a count time of 3 s per step. The sample
stage was spun at 30 rpm. The instrument was calibrated prior to
use, using a silicon standard.
2.6. Differential scanning calorimetry (DSC)
Differential scanning calorimetry (DSC) thermograms were
obtainedusing a Perkin-Elmer Series 7DSC (Perkin-Elmer Ltd., Bea-
consﬁeld, UK). Samples (4–7mg) were sealed in aluminium pans.
The escape of water was facilitated by placing a pinhole in the lid
prior to sealing. The samples were equilibrated at 30 ◦C and heated
to 210 ◦C at a scan rate of 10 ◦C/min under a ﬂow of anhydrous
nitrogen (20ml/min). Each sample was analysed in triplicate. The
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temperature axis and cell constant of the DSC cell were calibrated
with indium (10mg, 99.999% pure, melting point 156.60 ◦C, and
heat of fusion 28.40 J/g).
2.6.1. Evaluation of microcalorimetric data
Tm and calorimetric transition enthalpies (HCal) were mea-
sured byDSC, and then the cooperative unit size (n′) was calculated
after baseline correction using the following equation:
n′ = HvH
HCal
(1)
where HvH is the corresponding van’t Hoff enthalpy of the unfol-
ding. Bammel et al. [20] indicated that HvH can be obtained from:
HvH =
4RT2mCp (max)
HCal
(2)
where R is the universal gas constant (8.314×10−3 kJ/K/mol),
Cp (max) is the maximum heat capacity and it is calculated from:
Cp (max) = peakheight(scan rate × sampleweight) (3)
2.7. FT-Raman spectroscopy
FT-Raman spectra of sampleswere recordedwith a Bruker IFS66
optics systemusingaBrukerFRA106Ramanmodule. Theexcitation
sourcewas anNd:YAG laser operating at 1064nmanda laser power
of50mWwasused. TheFT-Ramanmodule is equippedwitha liquid
nitrogen cooled germanium diode detector with an extended spec-
trumbandwidth covering thewavenumber range 1800–450 cm−1.
Samples were placed in stainless steel sample cups and scanned
200 times with the resolution set at 8 cm−1. The observed band
wave numbers were calibrated against the internal laser frequency
and are correct to better than ±1 cm−1. The spectra were corrected
for instrument response. The experiments were run at a controlled
room temperature of 20±1 ◦C.
2.8. Enzymatic assay
Lysozyme catalyzes the hydrolysis of -1,4-glycosidic linkages
of cell-wall mucopolysaccharides [18]. This principle was used to
measure the activity of lysozyme as follows. 30l of lysozyme
solution 0.05% in phosphate buffer (pH=5.2; 10mM) was added
to 2.97ml substrate bacterial suspension 0.025% of M. lysodeikti-
cus in phosphate buffer (pH=6.24; 66mM). The decrease in the
absorptionat 450nmwasmonitoredbyusingaUV–vis spectropho-
tometer (Pu 8700, Philips, UK). The activity was determined by
measuring the decrease in the substrate bacterial suspension con-
centration with time. Hence the slope of the reduction in the light
absorption at 450nm against the time of 3min, starting when the
protein solutions were mixed with the substrate bacterial suspen-
sion, was considered to be the indicator of the activity [21]. The
measurements were performed in controlled temperature room at
20 ◦C to avoid ﬂuctuation of lysozyme activity. The concentrations
of the protein solutions had been determined prior to the activity
tests using the following equation.
[Protein] = Abs280 nm
E280 nm
(4)
where [protein] is the concentration of protein in the tested solu-
tionw/v%, Abs280 nm is the absorption of the tested protein solution
at 280nm, E280 nm is the absorption of protein standard solution
with concentration 0.05 w/v%. The concentrations of the solutions
were diluted to be about 0.05% w/v so as to give absorption of less
than 0.8. The activities of all samples were measured relative to
that of a corresponding fresh sample, which was considered as the
standard solution.
Fig. 1. Example TGA thermograms of lysozyme (A) crystals (B) dried crystals. Con-
ditions: samples heated from 30 to 210 ◦C; heating rate: 10 ◦C/min.
3. Results and discussion
3.1. Microscopy
Fig. S1 shows the photomicrograph of a lysozyme crystal. The
anisotropic crystals exhibited a birefringence phenomenon when
viewed under a polarizing microscope. The elongated prism-like
crystals were in general of a projected area diameter of ∼1200m
(Fig. S1). Their shape was consistent with their preparation tem-
perature, which was 20 ◦C. The crystal shape of lysozyme is known
to be affected by temperature, and a temperature of ∼20 ◦C usually
results in elongated prism-like crystals [22]. Samples 3M, 10M,
20M, and 30M had diameters of ∼80m (Fig. S2), ∼7m (Fig. S3),
∼2.5m (Fig. S4), and less than 1m (Fig. S5), respectively.
3.2. Thermogravimetric analysis (TGA)
The results of TGA analysis were used to estimate the water
content of the crystal forms. The thermograms (Fig. 1) indicate that
on drying using the conditions described above, the water content
decreased from 17.3±1.0% w/w to 2.6±0.3% w/w. The obtained
values of water content in protein powders using TGA were previ-
ously shown to be consistent with Karl Fischer titration data [13].
3.3. X-ray powder diffraction (XRPD)
The diffractogram presented in Fig. 2A shows an absence of
diffraction peaks for the unprocessed lysozyme powder indicating
that it was amorphous. However, in Fig. 2B diffraction peaks for the
lysozyme crystals at 2 angles less than 8◦ are present. Proteins are
large molecules and are crystallized typically in unit cells having
high d values, and so according to Bragg’s law, lysozyme crystals
are expected to diffract X-ray at low 2 angles.
Fig. 2. PXRD patterns of lysozyme powders (A) unprocessed, (B) crystals, (C) dried
crystals, (D) dried crystals milled for 3min (3M), (E) dried crystals milled for 10min
(10M), and (F) dried crystals milled for 20min (20M).
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Because lysozyme crystals exist in different forms, the CMPR
program (Version 1.32) [23]was employed for phase identiﬁcation.
The observed PXRDpeaks of the crystals at 2.82◦, 3.56◦, 4.47◦, 5.21◦,
6.09◦, and 6.97◦ (Fig. 2B) ﬁtted the faces (H,K,L) {(1,1,1), (3,1,0),
(4,0,0), (4,1,1), (4,3,1), (5,3,1)} of the tetragonal form of lysozyme
with parameters A=78.54, B=78.54 and C=37.77, ˛=ˇ = =90◦
taken from protein data bank reference number 193L [24].
Dried lysozyme crystals were also characterised using PXRD
and data indicated that the degree of crystallinity was predomi-
nantly maintained. The fact that the intensity of the XRPD peaks,
which did not notably change (Fig. 2C), was evidence to this effect.
Minor up shifting in the diffracted peaks after drying was noticed.
This can be due to shrinkage of the unit cell to lower d values
upon dehydration. The cell volume of tetragonal lysozyme crystals
shrunk under the effect of pressure without a loss in its diffraction
property [25]. Our XRPD ﬁnding agrees with previous results. For
example, both monoclinic and triclinic crystals of HEWL have been
shown to maintain their ability to diffract X-rays after dehydration
[26,27], respectively. However, it contradicts some previous low
frequency Raman spectra results, which showed that tetragonal
lysozyme crystals resulted in crystallinity loss and conversion into
an isotropic material (amorphous) after drying from ∼33.5% w/w
to ∼9% w/w water content by equilibrating at ∼30% r.h. [28,29].
In general, although dehydration ﬁrstly transfers a protein crystal
to a metastable state, which then collapses and loses its packing
structure, some crystals survive their crystallinity upon dehydra-
tion [26]. The ﬁndings of the present study would suggest that the
conditions of the drying process would play an important part as to
whether crystallinity is maintained. Thus if protein crystals are to
be used as a drug delivery vehicle after bulk crystallisation then the
subsequentmilling and drying conditionswill require close control
and monitoring to obtain consistent results.
Milling of the dried crystals did produce a loss in crystallinity.
XRPD was able to follow the loss of crystallinity of dried lysozyme
crystalswith comminution time. In case of 3M, the 3 minofmilling
did not induce crystallinity loss (Fig. 2D) as indicated by PXRD.
However, the intensity of the diffracted peaks of sample 10M
decreased (Fig. 2E). This indicates that lysozyme crystals became
partially disordered after only 10min of milling. Fig. 2F shows that
20min of milling was sufﬁcient to produce a diffractogram with no
clear peaks for the 20M sample, and so its XRPD spectrum became
similar to that of the amorphous lysozyme (unprocessed) (Fig. 2A)
which is consistent with transformation to the amorphous state.
3.4. Differential scanning calorimetry (DSC)
Lysozyme DSC thermograms, in the solid state, typically show
two endothermic peaks. The broad peak ranging from ∼30 to
∼140 ◦C is due to water removal, and its area depends on the
water residue in the samples. The second peak at ∼200 ◦C, and
its peak maximum was considered to reﬂect the apparent dena-
turation temperature (Tm) [13,14,18,19,30]. Fig. 3A shows a typical
lysozyme thermogramdemonstrating thepresenceof peaks at sim-
ilar positions to those mentioned above. Thermograms for all other
samples show a consistentwater removal peak. However, the posi-
tion and magnitude of Tm peak was found to depend on the solid
state form of the lysozyme powder. The differences observed from
DSC analysis align with the differences between the states previ-
ously observed by XRPD (Fig. 2). Amorphous lysozyme obtained as
received (unprocessed lysozyme) thermally peaked at a Tm of about
∼201 ◦C (Fig. 3A), while samples of crystalline lysozyme (crystals,
dried crystals, or the minimally milled 3M sample) gave a lower Tm
of about ∼187 ◦C (Fig. 4B–D). Evidence that the 10M sample was
transformed partially to an amorphous form was apparent from
inspection of the DSC thermal scan since it contained two distinct
Tm’s consistent with amorphous and crystalline lysozyme forms
Fig. 3. Example DSC thermograms of lysozyme (A) unprocessed, (B) crystals, (C)
dried crystals, (D) dried crystals milled for 3min (3M), (E) dried crystals milled
for 10min (10M), (F) dried crystals milled for 20min (20M), (G) dried crystals
milled for 30min, (H) dried crystals milled for 45min (45M), and (I) dried crys-
tals milled for 60min (60M). Conditions: samples heated from 30 to 210 ◦C; heating
rate: 10 ◦C/min.
respectively at separate Tm of ∼187 and ∼201 ◦C (Fig. 3E). Similar to
the XPRD evidence above, DSC data suggested that further milling
completed the amorphous transformation, with the 20M sample
being amorphous, and hence it only had the Tm of an amorphous
state at ∼201 ◦C (Fig. 3F).
Close scrutiny of the thermograms showed that for sample 20M
(amorphous lysozyme), Tm was slightly decreased by only ∼1 ◦C
compared to that of the other amorphous lysozyme (unprocessed
sample). However, this small difference was signiﬁcant (t-test:
P<0.05) (Table 1). This minor reduction is likely to be due to the
presence of NaCl content in the former sample. The amount of NaCl
in the lysozyme crystal is approximated to be ∼10 NaCl molecules
for each lysozyme molecule. At the preparation pH, each molecule
of lysozyme needed ∼10 Cl− ions of NaCl to shield its positive
charges, which induce the repulsion between lysozyme molecules.
This shielding by counter ions of the precipitant (NaCl) is necessary
to start nucleationand formcrystals inwhich these ions are trapped
[31]. The precipitated samples which were precipitated with dif-
ferent salt contents (P0, P24, P40, and P200) revealed a strong
inverse relationship between salt content and Tm (correlation coef-
ﬁcient r=−0.92). The values of Tm were 202.2±0.3, 200.3±0.5,
198.2±0.5, and195.8±0.2, respectively, and their DSCproﬁles and
amorphousPXRDpatterns areprovided in supplementarydata (Fig.
S6andFig. S7). Therefore, according to this correlation, thepresence
of around 10 NaCl molecules for each lysozyme molecule reduces
Tm by ∼1 ◦C.
Fig. 4. Correlation between the milling time and the calorimetric unfolding
enthalpies of the milled lysozyme crystals (A) the enthalpy of the crystalline con-
tent, (B) the enthalpy of the amorphous content and (C) the enthalpy of the total
contents (crystalline and amorphous).
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Table 1
Apparent denaturation temperature (Tm), calorimetric enthalpy (HCal), Van’t Hoff enthalpy (HvH), and cooperative unit (n′) of lysozyme samples in the solid state;
determined by differential scanning calorimetry (DSC). Conditions: samples heated from 30 to 210 ◦C; heating rate: 10 ◦C/min.
Lysozyme samples Tm (◦C) HCal (kJ/mol) HvH (kJ/mol) n′
Unprocessed 202.3 (0.5) 134.1 (4.6) 1400.9 (35.6) 10.4 (0.6)
Crystals 187.3 (0.3) 125.3 (7.2) 1045.9 (82. 6) 8.3 (0.7)
Dried crystals 187.8 (0.7) 127.0 (4.2) 1016.1 (39.7) 8.0 (0.5)
Milled dried crystal for 3min (3M) 187.9 (0. 6) 114.4 (1.2) 940.2 (79.1) 8.2 (0.8)
Milled dried crystal for 10min (10M) 187.5 (0.4) 38.0 (11.3) 307.9 (71.2) 8.1 (0. 5)
201.1 (0.2) 69.9 (8.5) 762.6 (61.3) 10.9 (0.4)
Milled dried crystals for 20min (20M) 201.0 (0.4) 105.9 (3.6) 1180.1 (60.7) 11.1 (0.6)
Milled dried crystals for 30min (30M) 200.8 (0.6) 52.8 (7.5) – –
Milled dried crystals for 45min (45M) 201.1 (0.5) 19.6 (2.9) – –
Milled dried crystals for 60min (60M) No peak – – –
Values within parenthesis are standard deviation, n=3.
The Tm of a protein does not necessarily represent a solid–liquid
transformation. Proteins do not melt, but they change their molec-
ular conformation from a native to denatured state at the Tm which
overcomes the attractive intra-molecular forces, which preserve
their native state. In solution state where lysozyme molecules
are well separated from each other by water molecules, the Tm
of lysozyme is ∼76 ◦C [32]. The cooperative unit (n′) is typically
thought to estimate the lowest number of molecules which form
an independentlymelting cluster ofmoleculeswithin a sample [33]
and is used as an indicator of the degree of unfolding cooperativity
of lysozyme [15]. In solution state, n′ of lysozyme solutions ranges
from 1 to 2 (i.e., ∼1.5) [34] Compared with the solution state, n′ of
lysozyme in the dried amorphous form (e.g. unprocessed or 20M
sample) was estimated to increase from ∼1.5 to ∼10.5, and this is
associated with the increase in Tm from ∼76 to ∼201 ◦C (Table 1).
We can postulate that when the cooperative unit increases, a
higher temperature is needed to unfold the lysozyme molecular
aggregates, and that the larger the cooperative unit, the higher the
Tm. The n′ of the crystalline form (e.g. crystals, dried crystals, 3M)
was lower than those of the amorphous form by ∼2.5unit (t-test:
P<0.05) (Table 1). This explains the reduction in Tm of the crys-
talline form by ∼14 ◦C compared to the amorphous form. Although
the unfolding of proteins is an intra-molecular phenomenon rather
than an inter-molecular phenomenon, the unfolding of a molecule
within amolecular aggregate is resisted by the steric hindrance and
repulsion of the other molecules in the unit.
Table 1 and Fig. 3 show that milling decreased the HCal of
the unfolding peak of the crystalline form (HCrCal) with a cor-
responding increase in the HCal of the unfolding peak of the
amorphous form (HAmCal ). When H
Cr
Cal vanished, H
Am
Cal reached a
maximum of 105.9 kJ/mol (as in the case of 20M sample), which
is lower than those of both the crystalline form (dried crys-
tals) and the amorphous form (unprocessed sample). Therefore,
the complete crystalline-amorphous transformation associated
with slightly mechanical denaturation (∼17%). The further milling
denatured gradually the amorphous form, as HAmCal decreased
gradually by milling (i.e., 30M and 45M samples). Prolonged
milling of dried crystals produced thermal evidence of a loss of
unfolding due to the absence of a Tm as in the case of 60M
(Fig. 3I). Fig. 4 summarizes the correlation between the milling
time and the calorimetric unfolding enthalpies of the crystalline
and amorphous peaks. This observation coupled with the milling
data discussed above is suggestive that milling initially induced
a partial crystalline-amorphous transformation, followed by a
complete amorphization transformation, and then on subsequent
prolonged milling produced complete mechanical denaturation.
Although a small part of lysozyme molecules denatured during
the crystalline-amorphous transformation, the mechanical dena-
turation of crystalline lysozyme mainly goes through amorphous
state. Similarly, the other two batches of 3M, 10M, 20M and 60M
veriﬁed the crystalline-amorphous-denatured transformations of
lysozyme powders during milling and the distinctive thermal
behaviours of each form (Table 2).
3.4.1. Quantitative analysis of lysozyme solid states by DSC
Conventional DSC has been used to estimate the different solid
phases in lactose powders. The estimation depended on knowing
the enthalpy of solid phase transformation for each form. This DSC
approach has been previously veriﬁed [35].
Applying the same approach to monitor the processing of
the lysozyme powders, crystalline lysozyme (i.e. crystals) and
amorphous lysozyme (i.e. unprocessed powder) produced sim-
ilar enthalpies (t-test: P>0.05), with an average of 125 and
134kJ/mol, respectively. Therefore, these values were considered
as the enthalpy of the native solid lysozyme.Weassume thatmilled
solid lysozyme powders would consist of mixtures of crystalline,
amorphous and/or denatured lysozyme. The percentages of crys-
talline form (Cr%), amorphous form (Am%), and denatured form
(De%) in the lysozyme powders can be determined from:
Cr% =
(
H∼187Cal
125
)
× 100 (5)
Am% =
(
H∼201Cal
134
)
× 100 (6)
De% = 100 − (Cr% + Am%) (7)
Table 2
Apparentdenaturation temperature (Tm), calorimetric enthalpy (HCal) of the secondand thirdbatchesof themilled lysozymesamples (3M,10M,20Mand60M);determined
by differential scanning calorimetry (DSC). Conditions: samples heated from 30 to 210 ◦C; heating rate: 10 ◦C/min.
Lysozyme samples Second batch Third batch
Tm (◦C) HCal (kJ/mol) Tm (◦C) HCal (kJ/mol)
Milled dried crystal for 3min (3M) 187.4 (1.1) 122.3 (3.7) 188.4 (0.7) 119.7 (8.9)
Milled dried crystal for 10min (10M) 188.2 (0.7) 48.9 (6.2) 187.1 (0.9) 37.4 (3.6)
200.9 (0.5) 64.8 (5.9) 200.1 (1.2) 74.9 (7.1)
Milled dried crystals for 20min (20M) 200.6 (0.9) 112.8 (4.6) 200.9 (0.8) 109.2 (5.2)
Milled dried crystals for 60min (60M) No peak – No peak –
Values within parenthesis are standard deviation, n=3.
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Table 3
Apparent denaturation temperature (Tm), calorimetric enthalpy (HCal), and the percentages of crystalline (Cr%), amorphous (Am%), and denatured (De%) in the mixtures of
amorphous lysozyme (unprocessed) and crystalline lysozyme (3M) samples at different ratios; determined by differential scanning calorimetry (DSC). Conditions: samples
heated from 30 to 210 ◦C; heating rate: 10 ◦C/min.
Mixtures Crystalline Peak Amorphous peak Cr% Am% De%
Tm (◦C) HCal (kJ/mol) Tm (◦C) HCal kJ/mol
Unprocessed/3M (3:7) 187.1 (0.7) 79.1 (8.0) 201.8 (0.4) 41.8 (6.0) 63.3 (6.4) 31.2 (4.5) 5.5 (1.6)
Unprocessed/3M (5:5) 188.1 (0.5) 58.6 (4.9) 202.1 (0.3) 63.4 (7.0) 46.9 (3.9) 47.3 (5.2) 5.8 (2.0)
Unprocessed/3M (7:3) 187.6 (0.3) 43.5 (6.9) 202.2 (0.8) 82.5 (8.7) 34.8 (5.5) 61.6 (6.5) 3.6 (1.4)
Values within parenthesis are standard deviation, n=3.
where H∼187Cal and H
∼201
Cal are the measured enthalpy (kJ/mol) of
the unfolding peaks at Tm of ∼187 and ∼201 ◦C, respectively.
To test the quantitative hypothesis amorphous lysozyme
(unprocessed sample) and crystalline lysozyme (3M sample) were
mixed at different ratios of 3:7, 5:5, and 7:3 and then they ana-
lysed by DSC (same procedures). According to Eqs. (5)–(7), the
amorphous sample contains 100% native lysozyme, but the crys-
talline sample, which had H∼187Cal = 114.4kJ/mol, contains 91.5%
native and 8.5% denature lysozyme. Therefore, the three mixtures
of unprocessed: 3M (3:7, 5:5 and 7:3) should contain (27.4%, 70.0%,
2.6%), (45.7%, 50.0%, 4.3%) and (64.0%, 30.0%, 6.0%) of (Cr%, Am%, and
De%), respectively. These calculated crystalline, amorphous and
denatured percentages using the above equations were similar to
the actual percentages in themixtures listed in Table 3. Fig. 5 shows
the distinctive unfolding peaks of the crystalline and amorphous
forms of the mixtures.
3.5. FT-Raman study
Raman spectroscopy was used to compare the molecular con-
formation of crystalline (3M sample), amorphous lysozyme (20M
sample) and extensively milled (denatured) lysozyme (60M sam-
ple) with dried lysozyme crystals. The band at 1447 cm−1 indicates
Fig. 5. Expanded DSC thermograms showing the unfolding transition peaks of mix-
tures of amorphous lysozyme (unprocessed): crystalline lysozyme (3M) samples at
different ratios of (A) 3:7, (B) 5:5, and (C) 7:3. Conditions: samples heated from 30
to 210 ◦C; heating rate: 10 ◦C/min.
the CH bending vibrations of aliphatic side chains, and its intensity
andposition areunaffectedby changes induced inprotein structure
after dehydration or applying different stresses [36]. Therefore, it
wasused as internal intensity standard tonormalize Raman spectra
before comparison (Fig. 6A).
Fig. 6. FT-Raman spectra of dried crystals (linewithoutmarker), 3Msample (crystalline lysozyme) (cross), 20Msample (amorphous) (square) and60M(denatured lysozyme)
(triangle). Vibration modes are (B) back bone, (C) amide III and (D) amide I. The spectra were normalized using the methylene deformation mode at 1448 cm−1 as an internal
intensity standard.
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Table 4
The effect of pharmaceutical operations including milling time on the enzymatic
activity of lysozyme powders.
Lysozyme samples % Activity
Unprocessed 100.0 (1.5)
Crystals 102.3 (2.0)
Dried crystals 100.1 (2.9)
Milled dried crystal for 3min (3M) 100.4 (1.8)
Milled dried crystal for 20min (20M) 101.3 (2.7)
Milled dried crystals for 60min (60M) 99.9 (1.6)
Values within parenthesis are standard deviation, n=3.
Compared to the amorphous form of lysozyme (20M sample),
the crystalline form (dried crystals and3Msample) showedgreater
intensity of theCa C Nmode at 930 cm−1 (Fig. 6B), andproduced
a higher vibration mode of amide III (N H in-plane bend+C N
stretch) at ∼1265 cm−1 (Fig. 6C) and a lower and sharper vibra-
tion mode of amide I (C O stretch) at ∼1660 cm−1 (Fig. 6D). The
intensity of Ca C N mode at 930 cm−1 [37], upshifting of amide
III (N H in-plane bend +C N stretch) [38], and downshifting and
sharpening of the line of amide I (C O stretch) at ∼1660 cm−1
[39] indicates a higher -helix content. This means that the crys-
talline form maintained the -helix structure of native lysozyme
more than the amorphous form. The native secondary structure
of lysozyme consists of three alpha helix regions extending 5–15,
24–34 and 88–96 amino acid residues [24].
Rich -helix structures have a low tendency to aggregate com-
pared to rich -sheet structures [15]. This possibly explains why
the crystalline form had less tendency to thermally unfold in
lower n′ compared to the amorphous form. Therefore, according
to our above postulation, the spectroscopic observation that the
crystalline form contains more alpha helix may explain why the
crystalline lysozyme unfolded at lower Tm.
Comparison of the spectrumof the denatured lysozyme (sample
60M) with that of the amorphous form shows that mechani-
cal denaturation induced further reduction in the intensity of
Ca C N mode at 930 cm−1 (Fig. 6B), which in turn implies a fur-
ther reduction in -helix content.
3.6. Enzymatic assay
Interestingly, milled samples did not show a reduction in bio-
logical activity (ANOVA: P>0.05) (Table 4). The ability of lysozyme
to re-nature ondissolution is a possible explanation for this ﬁnding.
Indeed, previous research has shown the strong refolding ability of
lysozymeupondissolution inaqueousmedia [40]. Likewise, despite
signiﬁcant loss of the Raman vibrations of lysozyme upon dena-
turation by -irradiation, the denatured lysozyme samples almost
fully recovered their biological activity on dissolution [39].
4. Conclusions
Bulk crystallisation of protein therapeutic molecules for con-
trolled drug delivery studies is of interest to the biopharmaceutical
industry. The complexity of biotherapeutic molecules is likely to
lead to complex material properties of crystals in the solid state.
Here we exemplify, using the model drug lysozyme, the effects
of processing lysozyme crystals and are able to show distinct dif-
ferences in the properties of the materials after processing which
could be used in optimising and controlling processes for the pur-
poses of quality by design.
By drying lysozyme crystals using a controlled method we were
able to evidence the removal of water and maintain crystallinity.
However, the size reduction of dried lysozyme crystals by milling
was shown to promote formation of an amorphous solid-state
form. Raman spectroscopy provided evidence that the amorphous
form was then denatured in the solid state by further milling. The
milling time was the critical attribute determining the extent of
the transformations. DSCwas successfully employed inmonitoring
the three different states of lysozyme (namely crystalline, amor-
phous, and denatured) in the solid state. The DSC thermogram of
the crystalline lysozyme exhibited Tm at ∼187 ◦C which was lower
than that of amorphous lysozyme by ∼14 ◦C. The mechanically
denatured lysozyme did not provide a thermal unfolding transi-
tion. The calorimetric enthalpies of the crystalline and amorphous
peakswere used to analyze quantitatively the three different states
of lysozyme. XRPD data were consistent with the crystallinity of
lysozyme identiﬁed by DSC. Interpretation of the Raman data from
the same samples is consistent with a crystalline form having a
lower tendency to aggregate due to its greater -helix rich struc-
ture compared to the amorphous form. Signiﬁcantly, although the
molecular arrangement and molecular conformation of lysozyme
changed during milling, its biological activity did not decrease.
Clearly, subtle changes in solid-state processing conditions of crys-
talline lysozyme can bring about major changes in its solid-state
properties. The effects of a wider range of milling variables, includ-
ing different mill types, on lysozyme solid-state transformations
and behaviour will be the subject of a future study.
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